Hideaki Uchiyama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hideaki Uchiyama has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
Yoshihiko Maehara
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Japan
18 shared publicationsToru Ikegami
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Japan
13 shared publicationsTomoharu Yoshizumi
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Japan
12 shared publicationsShinji Itoh
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Japan
10 shared publicationsYuji Soejima
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Japan
10 shared publicationsKen Shirabe
Department of Hepatobiliary and Pancreatic Surgery, Gunma University Hospital, Maebashi, Gunma, Japan
9 shared publications
Latest Publications
- Open Access
- 1 June 2020
- Published by AME Publishing Company in HepatoBiliary Surgery and Nutrition
- Vol. 9 (3) , 360-363
Prudent use of a left hepatic graft in adult-to-adult living donor liver transplantation: aiming for further securing donors’ safety
Prudent use of a left hepatic graft in adult-to-adult living donor liver transplantation: aiming for further securing donors’ safety
- 1 June 2020
- Published by AME Publishing Company in HepatoBiliary Surgery and Nutrition
- Vol. 9 (3) , 360-363
Open AccessPrudent use of a left hepatic graft in adult-to-adult living donor liver transplantation: aiming for further securing donors’ safety
Prudent use of a left hepatic graft in adult-to-adult living donor liver transplantation: aiming for further securing donors’ safety
- 1 June 2017
- Published by AME Publishing Company in HepatoBiliary Surgery and Nutrition
- Vol. 6 (3) , 196-199
Sarcopenia in liver transplant recipients: its relevance to peritransplant morbidity and mortality
Sarcopenia in liver transplant recipients: its relevance to peritransplant morbidity and mortality
- 1 June 2017
- Published by AME Publishing Company in HepatoBiliary Surgery and Nutrition
- Vol. 6 (3) , 196-199
Sarcopenia in liver transplant recipients: its relevance to peritransplant morbidity and mortality
Sarcopenia in liver transplant recipients: its relevance to peritransplant morbidity and mortality
- Open Access
- 28 April 2017
- Published by AME Publishing Company in Translational Gastroenterology and Hepatology
- Vol. 2 (4) , 34
Left hepatectomy with simultaneous hepatic artery and portal vein reconstructions in the operation for cholangiocarcinoma: the surgical techniques comprised of step-by-step established procedures
Hepatectomy needing simultaneous reconstruction of the hepatic artery and the portal vein in the operation for cholangiocarcinoma is a challenging procedure. We experienced three cases of left hepatectomy with simultaneous reconstructions of the right hepatic artery (RHA) and the right portal vein (RPV) in all of which the surgical procedures were performed in the same manner. At the initial step of the procedure, we confirmed that the RHA and the RPV at the porta hepatis as well as the proper hepatic artery and the main portal vein (MPV) proximal to the cancer involvement could be controlled by tapes, which meant the cancer could be resected by means of vascular reconstructions. All the vascular reconstructions were performed under loupe magnification. The mean periods of portal and arterial ischemic time of the remnant liver were 14 min. 32 sec. and 35 min. 58 sec., respectively. The mean operative time and the intraoperative blood loss were 627 min. and 804 mL, respectively. No serious postoperative complication occurred. By performing step-by-step well-established procedures, this complicated and challenging operation could be safely completed.
- 28 April 2017
- Published by AME Publishing Company in Translational Gastroenterology and Hepatology
- Vol. 2 (4) , 34
Open AccessLeft hepatectomy with simultaneous hepatic artery and portal vein reconstructions in the operation for cholangiocarcinoma: the surgical techniques comprised of step-by-step established procedures
Hepatectomy needing simultaneous reconstruction of the hepatic artery and the portal vein in the operation for cholangiocarcinoma is a challenging procedure. We experienced three cases of left hepatectomy with simultaneous reconstructions of the right hepatic artery (RHA) and the right portal vein (RPV) in all of which the surgical procedures were performed in the same manner. At the initial step of the procedure, we confirmed that the RHA and the RPV at the porta hepatis as well as the proper hepatic artery and the main portal vein (MPV) proximal to the cancer involvement could be controlled by tapes, which meant the cancer could be resected by means of vascular reconstructions. All the vascular reconstructions were performed under loupe magnification. The mean periods of portal and arterial ischemic time of the remnant liver were 14 min. 32 sec. and 35 min. 58 sec., respectively. The mean operative time and the intraoperative blood loss were 627 min. and 804 mL, respectively. No serious postoperative complication occurred. By performing step-by-step well-established procedures, this complicated and challenging operation could be safely completed.
- 1 April 2017
- Published by AME Publishing Company in ASVIDE
- Vol. 4 (1) , 183
The representative left hepatectomy with simultaneous hepatic artery and portal vein reconstructions in the operation for cholangiocarcinoma
- 1 April 2017
- Published by AME Publishing Company in ASVIDE
- Vol. 4 (1) , 183
The representative left hepatectomy with simultaneous hepatic artery and portal vein reconstructions in the operation for cholangiocarcinoma
- Open Access
- 1 February 2017
- Published by Springer Nature in Surgical Case Reports
- Vol. 3 (1) , 21
Liver transplantation for cryptogenic liver failure caused by diffuse hepatic angiosarcoma: case report
Primary hepatic angiosarcoma is a non-epithelial malignancy derived from sinusoidal endothelial cells, accounting for approximately 1.8% of primary hepatic malignancies. Diagnosis of primary hepatic angiosarcoma is complicated by difficulties in the qualitative radiological assessment of these tumors. Prognosis is very poor due to local recurrence and distant metastasis after liver resection or liver transplantation (LT). This case report describes two patients with primary hepatic angiosarcoma who were diagnosed by histopathological examination of the explanted liver after LT. One patient had undergone living donor LT, and the other had undergone deceased donor LT. Neither showed evidence of malignancy on the pre-operative imaging tests. Hepatic angiosarcoma has a very high relapse rate after LT. Pre-transplant liver biopsy may be necessary to distinguish diffuse hepatic angiosarcoma from tumors of other origin in patients with cryptogenic liver failure.
- 1 February 2017
- Published by Springer Nature in Surgical Case Reports
- Vol. 3 (1) , 21
Open AccessLiver transplantation for cryptogenic liver failure caused by diffuse hepatic angiosarcoma: case report
Primary hepatic angiosarcoma is a non-epithelial malignancy derived from sinusoidal endothelial cells, accounting for approximately 1.8% of primary hepatic malignancies. Diagnosis of primary hepatic angiosarcoma is complicated by difficulties in the qualitative radiological assessment of these tumors. Prognosis is very poor due to local recurrence and distant metastasis after liver resection or liver transplantation (LT). This case report describes two patients with primary hepatic angiosarcoma who were diagnosed by histopathological examination of the explanted liver after LT. One patient had undergone living donor LT, and the other had undergone deceased donor LT. Neither showed evidence of malignancy on the pre-operative imaging tests. Hepatic angiosarcoma has a very high relapse rate after LT. Pre-transplant liver biopsy may be necessary to distinguish diffuse hepatic angiosarcoma from tumors of other origin in patients with cryptogenic liver failure.
- 21 December 2016
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 23 (1) , 110-116
Use of internal jugular vein grafts in reconstructing multiple venous orifices of right hepatic grafts without the middle hepatic vein trunk
- 21 December 2016
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 23 (1) , 110-116
Use of internal jugular vein grafts in reconstructing multiple venous orifices of right hepatic grafts without the middle hepatic vein trunk
- 23 November 2016
- Published by Wiley in World Journal of Surgery
- Vol. 41 (4) , 1089-1099
Pleural Effusion After Hepatectomy for Hepatocellular Carcinoma: Risk Factor Analyses and Its Impact on Oncological Outcomes
Background: Although posthepatectomy pleural effusion (PHPE) is a commonly observed phenomenon, its precise etiology and the impact of its emergence on oncological outcomes have still unknown. The aim of the current study was to retrospectively investigate risk factors for PHPE and its impact on oncological outcomes of hepatocellular carcinoma (HCC).Methods: Medical records of 330 patients who underwent primary curative hepatectomy for HCC were reviewed. All 330 patients had CT around day 7 after hepatectomy, and the emergence of PHPE on CT was examined. Presumed 38 risk factors for the emergence of PHPE and already‐known 9 risk factors together with PHPE for HCC recurrence and patient death after hepatectomy were analyzed.Results: The overall incidence of PHPE was 54.5% (180/330). One hundred seventy‐nine and 38 out of the 180 patients had right‐sided PHPE and left‐sided PHPE, respectively. The independent risk factors for right‐sided PHPE were hepatitis B or C back ground, lower preoperative white blood cell count, larger intraoperative blood loss, longer operation time, subcostal incision, and longer total inflow occlusion time, while the only independent risk factor for left‐sided PHPE was longer operation time. Left‐sided PHPE was testified to be one of the independent risk factors not only for HCC recurrence but also for patient death.Conclusions: Although the cause of PHPE after hepatectomy might be multifactorial, the emergence of left‐sided PHPE is a portent of worse oncological outcomes after curative hepatectomy for HCC and patients with left‐sided PHPE need close follow‐ups.
- 23 November 2016
- Published by Wiley in World Journal of Surgery
- Vol. 41 (4) , 1089-1099
Pleural Effusion After Hepatectomy for Hepatocellular Carcinoma: Risk Factor Analyses and Its Impact on Oncological Outcomes
Background: Although posthepatectomy pleural effusion (PHPE) is a commonly observed phenomenon, its precise etiology and the impact of its emergence on oncological outcomes have still unknown. The aim of the current study was to retrospectively investigate risk factors for PHPE and its impact on oncological outcomes of hepatocellular carcinoma (HCC).Methods: Medical records of 330 patients who underwent primary curative hepatectomy for HCC were reviewed. All 330 patients had CT around day 7 after hepatectomy, and the emergence of PHPE on CT was examined. Presumed 38 risk factors for the emergence of PHPE and already‐known 9 risk factors together with PHPE for HCC recurrence and patient death after hepatectomy were analyzed.Results: The overall incidence of PHPE was 54.5% (180/330). One hundred seventy‐nine and 38 out of the 180 patients had right‐sided PHPE and left‐sided PHPE, respectively. The independent risk factors for right‐sided PHPE were hepatitis B or C back ground, lower preoperative white blood cell count, larger intraoperative blood loss, longer operation time, subcostal incision, and longer total inflow occlusion time, while the only independent risk factor for left‐sided PHPE was longer operation time. Left‐sided PHPE was testified to be one of the independent risk factors not only for HCC recurrence but also for patient death.Conclusions: Although the cause of PHPE after hepatectomy might be multifactorial, the emergence of left‐sided PHPE is a portent of worse oncological outcomes after curative hepatectomy for HCC and patients with left‐sided PHPE need close follow‐ups.
- Open Access
- 4 July 2016
- Published by Springer Nature in Surgical Case Reports
- Vol. 2 (1) , 69
A long survivor with local relapse of hilar cholangiocarcinoma after R1 surgery treated with chemoradiotherapy: a case report and literature review
The treatment outcome of extrahepatic cholangiocarcinoma remains insufficient because it is difficult to obtain accurate diagnosis of tumor spreading and effective treatment agent is quite limited in spite of substantial current efforts, all of which have been unsuccessful except for gemcitabine plus cisplatin. The patient was a 60-year-old female who had developed hilar cholangiocarcinoma and underwent extrahepatic bile duct resection. Although it was conceivable that it would be the R1 resection, the patient wanted to receive limited resection to avoid postoperative complication mainly because she was depressed. In histology, interstitial spreading of tumor was appreciated at the surgical margin of bile duct. The patient did not accept to receive the additional treatment after the surgery and hardly visited the hospital to take the periodical test for monitoring the residual cancer cells. As expected, the local relapse of tumor was appreciated 1 year after the R1 surgery. She chose radiotherapy and agreed with subsequent S-1 treatment for 26 months. Consequently, elevated CA19-9 was decreased, and local relapse has been successfully controlled for more than 7 years after the relapse of tumor. Here, we report quite a rare case in terms of long survivor after chemoradiotherapy on locally relapsed unresectable hilar cholangiocarcinoma.
- 4 July 2016
- Published by Springer Nature in Surgical Case Reports
- Vol. 2 (1) , 69
Open AccessA long survivor with local relapse of hilar cholangiocarcinoma after R1 surgery treated with chemoradiotherapy: a case report and literature review
The treatment outcome of extrahepatic cholangiocarcinoma remains insufficient because it is difficult to obtain accurate diagnosis of tumor spreading and effective treatment agent is quite limited in spite of substantial current efforts, all of which have been unsuccessful except for gemcitabine plus cisplatin. The patient was a 60-year-old female who had developed hilar cholangiocarcinoma and underwent extrahepatic bile duct resection. Although it was conceivable that it would be the R1 resection, the patient wanted to receive limited resection to avoid postoperative complication mainly because she was depressed. In histology, interstitial spreading of tumor was appreciated at the surgical margin of bile duct. The patient did not accept to receive the additional treatment after the surgery and hardly visited the hospital to take the periodical test for monitoring the residual cancer cells. As expected, the local relapse of tumor was appreciated 1 year after the R1 surgery. She chose radiotherapy and agreed with subsequent S-1 treatment for 26 months. Consequently, elevated CA19-9 was decreased, and local relapse has been successfully controlled for more than 7 years after the relapse of tumor. Here, we report quite a rare case in terms of long survivor after chemoradiotherapy on locally relapsed unresectable hilar cholangiocarcinoma.
- 3 July 2016
- Published by Wiley in Clinical Transplantation
- Vol. 30 (9) , 1021-1027
The use of left grafts with a replaced or accessory left hepatic artery in adult‐to‐adult living donor liver transplantation: analyses of donor and recipient outcomes
In living donor liver transplantation (LDLT), a left hepatic graft occasionally includes a replaced or accessory left hepatic artery (LHA). The procuring of such grafts requires extensive dissection along the lesser curvature of the stomach to elongate the replaced or accessory LHA on the donor side. On the recipient side, complicated arterial reconstruction is often necessary to use such grafts. We retrospectively reviewed the medical records of 206 adult recipients who underwent LDLT and their respective donors. The recipients and donors were divided into two groups according to the presence of the replaced or accessory LHA. Twenty‐five grafts included a replaced or accessory LHA. Only one hepatic artery‐related complication was observed in the current series, in which a pseudoaneurysm arose at the site of anastomosis between the donor accessory LHA and the recipient LHA. There was no increase in the incidence of postoperative complications in the donors with a replaced or accessory LHA in comparison with the donors without these arteries. The use of left hepatic grafts that included a replaced LHA or accessory LHA did not have any negative impact on the outcomes on either the donor or the recipient side.
- 3 July 2016
- Published by Wiley in Clinical Transplantation
- Vol. 30 (9) , 1021-1027
The use of left grafts with a replaced or accessory left hepatic artery in adult‐to‐adult living donor liver transplantation: analyses of donor and recipient outcomes
In living donor liver transplantation (LDLT), a left hepatic graft occasionally includes a replaced or accessory left hepatic artery (LHA). The procuring of such grafts requires extensive dissection along the lesser curvature of the stomach to elongate the replaced or accessory LHA on the donor side. On the recipient side, complicated arterial reconstruction is often necessary to use such grafts. We retrospectively reviewed the medical records of 206 adult recipients who underwent LDLT and their respective donors. The recipients and donors were divided into two groups according to the presence of the replaced or accessory LHA. Twenty‐five grafts included a replaced or accessory LHA. Only one hepatic artery‐related complication was observed in the current series, in which a pseudoaneurysm arose at the site of anastomosis between the donor accessory LHA and the recipient LHA. There was no increase in the incidence of postoperative complications in the donors with a replaced or accessory LHA in comparison with the donors without these arteries. The use of left hepatic grafts that included a replaced LHA or accessory LHA did not have any negative impact on the outcomes on either the donor or the recipient side.